ZA912228B - Compositions comprising cytotoxic agent and permeation enhancers - Google Patents

Compositions comprising cytotoxic agent and permeation enhancers

Info

Publication number
ZA912228B
ZA912228B ZA912228A ZA912228A ZA912228B ZA 912228 B ZA912228 B ZA 912228B ZA 912228 A ZA912228 A ZA 912228A ZA 912228 A ZA912228 A ZA 912228A ZA 912228 B ZA912228 B ZA 912228B
Authority
ZA
South Africa
Prior art keywords
compositions
cytotoxic agent
permeation enhancers
enhancers
permeation
Prior art date
Application number
ZA912228A
Other languages
English (en)
Inventor
Michel J N Cormier
J N Cormier Michel
Lina T Taskovich
T Taskovich Lina
Su Ii Yum
Ii Yum Su
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of ZA912228B publication Critical patent/ZA912228B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA912228A 1990-03-30 1991-03-25 Compositions comprising cytotoxic agent and permeation enhancers ZA912228B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50248890A 1990-03-30 1990-03-30

Publications (1)

Publication Number Publication Date
ZA912228B true ZA912228B (en) 1991-12-24

Family

ID=23998069

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA912228A ZA912228B (en) 1990-03-30 1991-03-25 Compositions comprising cytotoxic agent and permeation enhancers

Country Status (9)

Country Link
EP (1) EP0522006A1 (ja)
JP (1) JPH05505807A (ja)
AU (1) AU633207B2 (ja)
CA (1) CA2038969A1 (ja)
FI (1) FI924344A0 (ja)
IE (1) IE910976A1 (ja)
PT (1) PT97139A (ja)
WO (1) WO1991015210A1 (ja)
ZA (1) ZA912228B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU753018B2 (en) * 1996-06-19 2002-10-03 Novartis Ag Cyclosporin-containing soft capsule preparations
EP1413297B1 (en) * 1996-06-19 2008-04-23 Novartis AG Cyclosporin-containing preparations
AU722285B2 (en) * 1996-06-19 2000-07-27 Novartis Ag Cyclosporin-containing soft capsule preparations
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
US5993787A (en) * 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations
NZ314702A (en) * 1997-04-29 1998-07-28 Bernard Charles Sherman Pharmaceutical composition comprising a cyclosporin in a solvent system of acetylated monoglycerides and a surfactant and optionally a hydrophilic solvent
WO2005079855A1 (es) * 2004-02-23 2005-09-01 David Quintanar Guerrero Composicion promotora de penetracion a base de esteres de acidos grasos de sacarosa
JP2022545370A (ja) * 2019-08-14 2022-10-27 ナノメティクス エルエルシー （ディー．ビー．エー ピーエイチディー バイオサイエンシズ） ウラシル皮膚医薬製剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE37447B1 (en) * 1972-04-05 1977-07-20 Procter & Gamble Dermatological compositions
US4865848A (en) * 1987-02-26 1989-09-12 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4849426A (en) * 1987-05-15 1989-07-18 Pearlman Dale L Method for treating actinic keratosis with cytotoxic agents

Also Published As

Publication number Publication date
CA2038969A1 (en) 1991-10-01
FI924344A (fi) 1992-09-28
JPH05505807A (ja) 1993-08-26
AU633207B2 (en) 1993-01-21
IE910976A1 (en) 1991-10-09
FI924344A0 (fi) 1992-09-28
PT97139A (pt) 1991-11-29
AU7562091A (en) 1991-10-30
EP0522006A1 (en) 1993-01-13
WO1991015210A1 (en) 1991-10-17

Similar Documents

Publication Publication Date Title
GB2256433B (en) Ink composition and components thereof
EP0475434A3 (en) Polymer composition and its use
IL100229A0 (en) N,o-sulphated heparosans,their preparation and pharmaceutical compositions containing them
GB9009529D0 (en) Biocide composition and use
EP0475904A3 (en) Mixtures and compositions containing phenothiazines
IL97122A0 (en) Aromatase-inhibiting androstendiones and pharmaceutical compositions containing them
GB9027614D0 (en) Antimicrobial composition and use
ZA912228B (en) Compositions comprising cytotoxic agent and permeation enhancers
GB9114526D0 (en) Compositions and use thereof
EP0440559A3 (en) Polyolefin composition and use thereof
EP0490307A3 (en) Composition for bicarbonate dialysis and its use
ZA911065B (en) Chemical and pharmaceutical compositions
NZ239483A (en) Phosphonopyrrolidine or -piperidine derivatives and pharmaceutical compositions
GB2244488B (en) Permeation reducing thermoplastic composition
GB9016027D0 (en) Composition and use
HUT57806A (en) Copolymer composition comprising copolymer and one or more lubricants
GB9007457D0 (en) Copolymer compositions
GB9412618D0 (en) Cytotoxic agent and its use
GB9412689D0 (en) Cytotoxic agent and its use
EP0342804A3 (en) Trioxane composition and insect-proofing agent
GB9025868D0 (en) Novel anti-viral and cytotoxic agent
EP0409268A3 (en) Trioxane composition and insect-proofing agent
GB9009530D0 (en) Composition and use
EP0547140A4 (en) Immunosuppressant composition
IL94658A0 (en) 1,5-diazabicyclodiones and pharmaceutical compositions containing them